Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11 » Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma
Please verify you are not a robot.
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11 » Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma
Please verify you are not a robot.